2m 2m 2m 2m 2m 2m 2m
ANI Pharmaceutic (ANIP)
NASDAQ
$70.22+$0.03 (+0.04%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.6BMarket Cap
- -28.16%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ANI Pharmaceutic (ANIP)
$70.22+$0.03 (+0.04%)
ANIP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $70.19 | ||
Change | -$1.27 (-1.78%) | ||
Open | $71.53 | ||
High | $71.92 | ||
Low | $69.58 | ||
Previous Close | $71.46 | ||
Volume | 413,599 | ||
30-Day Average Volume | 350,683 | ||
1-Week Change | -1.46% | ||
1-Month Change | -5.82% | ||
1-Year Change | -28.16% | ||
3-Year Change | 12.95% | ||
5-Year Change | 155.79% | ||
Fundamentals | |||
Shares Outstanding | 23.0M | ||
Total Assets | $1.5B | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $266.0M | ||
Net Income | $24.7M | ||
Free Cash Flow | $53.6M | ||
EBIT | $40.7M | ||
EBITDA | $60.4M | ||
Net Working Capital | $541.8M | ||
EPS | $1.05 | ||
Enterprise Value/EBITDA | 26 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 3 | ||
P/E | 67 | ||
PEG | -4 | ||
Price/Free Cash Flow | 30 | ||
Price/Operating Cash Flow | 28 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/04/2012 | ||
Earnings & Revenue